Based in the United Kingdom, F-star is a startup.
F-star is a clinical-stage company focused on developing bispecific antibody therapeutics, including a lead program targeting LAG-3 and PD-L1.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.